86 related articles for article (PubMed ID: 8649788)
1. Epitope analysis of the murine p53 tumour suppressor protein.
Lane DP; Stephen CW; Midgley CA; Sparks A; Hupp TR; Daniels DA; Greaves R; Reid A; Vojtesek B; Picksley SM
Oncogene; 1996 Jun; 12(11):2461-6. PubMed ID: 8649788
[TBL] [Abstract][Full Text] [Related]
2. Epitope analysis of the human p53 tumour suppressor protein.
Dolezalová H; Vojtĕsek B; Kovarík J
Folia Biol (Praha); 1997; 43(1):49-51. PubMed ID: 9158951
[TBL] [Abstract][Full Text] [Related]
3. Structural and kinetic analysis of p53-DNA complexes and comparison of human and murine p53.
Hall AR; Milner J
Oncogene; 1995 Feb; 10(3):561-7. PubMed ID: 7845681
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of epitopes on human p53 using phage-displayed peptide libraries: insights into antibody-peptide interactions.
Stephen CW; Helminen P; Lane DP
J Mol Biol; 1995 Apr; 248(1):58-78. PubMed ID: 7537340
[TBL] [Abstract][Full Text] [Related]
5. Linear antigenic sites defined by the B-cell response to human p53 are localized predominantly in the amino and carboxy-termini of the protein.
Legros Y; Lafon C; Soussi T
Oncogene; 1994 Jul; 9(7):2071-6. PubMed ID: 8208553
[TBL] [Abstract][Full Text] [Related]
6. The DNA binding activity of wild type p53 is modulated by blocking its various antigenic epitopes.
Wolkowicz R; Elkind NB; Ronen D; Rotter V
Oncogene; 1995 Mar; 10(6):1167-74. PubMed ID: 7535417
[TBL] [Abstract][Full Text] [Related]
7. Conformational changes in p53 analysed using new antibodies to the core DNA binding domain of the protein.
Vojtesek B; Dolezalova H; Lauerova L; Svitakova M; Havlis P; Kovarik J; Midgley CA; Lane DP
Oncogene; 1995 Jan; 10(2):389-93. PubMed ID: 7530828
[TBL] [Abstract][Full Text] [Related]
8. Mutations in p53 produce a common conformational effect that can be detected with a panel of monoclonal antibodies directed toward the central part of the p53 protein.
Legros Y; Meyer A; Ory K; Soussi T
Oncogene; 1994 Dec; 9(12):3689-94. PubMed ID: 7526318
[TBL] [Abstract][Full Text] [Related]
9. p53 autoantibodies from patients with colorectal cancer recognize common epitopes in the N- or C-terminus of p53.
Saleh J; Kreissler-Haag D; Montenarh M
Int J Oncol; 2004 Oct; 25(4):1149-55. PubMed ID: 15375567
[TBL] [Abstract][Full Text] [Related]
10. Allergenic and antigenic determinants of latex allergen Hev b 1: peptide mapping of epitopes recognized by human, murine and rabbit antibodies.
Chen Z; Van Kampen V; Raulf-Heimsoth M; Baur X
Clin Exp Allergy; 1996 Apr; 26(4):406-15. PubMed ID: 8732237
[TBL] [Abstract][Full Text] [Related]
11. The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostability.
Hansen S; Lane DP; Midgley CA
J Mol Biol; 1998 Jan; 275(4):575-88. PubMed ID: 9466932
[TBL] [Abstract][Full Text] [Related]
12. Sequences of antigenic epitopes of streptokinase identified via random peptide libraries displayed on phage.
Parhami-Seren B; Keel T; Reed GL
J Mol Biol; 1997 Aug; 271(3):333-41. PubMed ID: 9268662
[TBL] [Abstract][Full Text] [Related]
13. p53 autoantibodies from patients with head and neck cancer recognise common epitopes on the polypeptide chain of p53.
Saleh J; Brunner C; Gölzer R; Nastainczyk W; Montenarh M
Cancer Lett; 2006 Feb; 233(1):48-56. PubMed ID: 15913883
[TBL] [Abstract][Full Text] [Related]
14. Localization and fine mapping of antigenic sites on the nucleocapsid protein N of porcine reproductive and respiratory syndrome virus with monoclonal antibodies.
Meulenberg JJ; van Nieuwstadt AP; van Essen-Zandbergen A; Bos-de Ruijter JN; Langeveld JP; Meloen RH
Virology; 1998 Dec; 252(1):106-14. PubMed ID: 9875321
[TBL] [Abstract][Full Text] [Related]
15. Comparison of anti-p53 antibodies in immunoblotting.
Turpeinen M; Serpi R; Rahkolin M; Vähäkangas K
Biochem Biophys Res Commun; 2002 May; 293(2):850-6. PubMed ID: 12054549
[TBL] [Abstract][Full Text] [Related]
16. Structural immuno-analysis of human and porcine interferon gamma: identification of shared antigenic domain.
Kontsek P; Martens E; Vandenbroeck K; Kontseková E; Waschütza G; Sareneva T; Billiau A
Cytokine; 1997 Aug; 9(8):550-5. PubMed ID: 9245481
[TBL] [Abstract][Full Text] [Related]
17. Nucleotide sequence of the porcine p53 cDNA, and the detection of recombinant porcine p53 expressed in vitro with a variety of anti-p53 antibodies.
Burr PD; Argyle DJ; Reid SW; Nasir L
Oncogene; 1999 Sep; 18(35):5005-9. PubMed ID: 10490836
[TBL] [Abstract][Full Text] [Related]
18. Epitope discovery using bacteriophage display: the minimum epitope of an anti-IRBP antibody.
Tighe PJ; Powell-Richards A; Sewell HF; Fischer D; Donoso L; Dua HS
Exp Eye Res; 1999 Jun; 68(6):679-84. PubMed ID: 10375431
[TBL] [Abstract][Full Text] [Related]
19. Cryptic open reading frames in plasmid vector backbone sequences can provide highly immunogenic cytotoxic T-lymphocyte epitopes.
van Hall T; van de Rhee NE; Schoenberger SP; Vierboom MP; Verreck FA; Melief CJ; Offringa R
Cancer Res; 1998 Jul; 58(14):3087-93. PubMed ID: 9679975
[TBL] [Abstract][Full Text] [Related]
20. Xenogeneic human p53 DNA vaccination by electroporation breaks immune tolerance to control murine tumors expressing mouse p53.
Soong RS; Trieu J; Lee SY; He L; Tsai YC; Wu TC; Hung CF
PLoS One; 2013; 8(2):e56912. PubMed ID: 23457640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
